{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:29:04Z","timestamp":1767374944448,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study was to estimate cancer survival in Poland between 2000 and 2019 for malignant neoplasms of female genital organs (FGO). We calculated survival in cancer of vulva, vagina, cervix uteri, corpus uteri, ovary, and other unspecified female genital organs. Data were obtained from the Polish National Cancer Registry. We estimated age-standardized 5- and 10-year net survival (NS) with the life table method and the Pohar-Perme estimator using the International Cancer Survival Standard weights. Overall, 231,925 FGO cancer cases were included in the study. The overall FGO age-standardized 5-year NS was 58.2% (95% confidence interval (CI) 57.9\u201358.5%) and the 10-year NS 51.5% (51.5\u201352.3%). Between 2000 and 2004 and 2015\u20132018, the highest statistically significant increase in age-standardized 5-year survival was noted for ovarian cancer at\u2009+\u20095.6% (P\u2009&lt;\u20090.001). The FGO cancer median survival time was 8.8\u00a0years (8.6\u20138.9\u00a0years), with a standardized mortality rate of 6.1 (6.0\u20136.1), and with cause-specific years of life lost at 7.8\u00a0years (7.7\u20137.8\u00a0years). Hazard ratios (HR) increased with age at diagnosis (HR\u2009=\u20091.02, 95% CI 1.01\u20131.03, P\u2009=\u20090.001). Although FGO cancer survivorship has been consistently improving during the last twenty years, additional efforts need to be undertaken to improve survivorship in several FGO cancers.<\/jats:p>","DOI":"10.1038\/s41598-023-35749-6","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:02:02Z","timestamp":1685008922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Survival of patients with cancers of the female genital organs in Poland, 2000\u20132019"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-3585","authenticated-orcid":false,"given":"Florentino Luciano","family":"Caetano dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-1384","authenticated-orcid":false,"given":"Urszula","family":"Wojciechowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8367-5916","authenticated-orcid":false,"given":"Irmina Maria","family":"Michalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-9118","authenticated-orcid":false,"given":"Joanna","family":"Didkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"issue":"3","key":"35749_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"35749_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay, J. et al. Cancer statistics for the year 2020: An overview. Int. J. Cancer 149(4), 778\u2013789 (2021).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"35749_CR3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1186\/s12885-019-6139-6","volume":"19","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Global patterns and trends in ovarian cancer incidence: Age, period and birth cohort analysis. BMC Cancer 19(1), 984 (2019).","journal-title":"BMC Cancer"},{"issue":"suppl 3","key":"35749_CR4","doi-asserted-by":"publisher","first-page":"e20190889","DOI":"10.1590\/0034-7167-2019-0889","volume":"74","author":"MVC Mendes","year":"2021","unstructured":"Mendes, M. V. C., Santos, S. L. D., Ceballos, A., Furtado, B. & Bonfim, C. V. D. Risk factors for suicide in individuals with cancer: An integrative literature review. Rev. Bras. Enferm. 74(suppl 3), e20190889 (2021).","journal-title":"Rev. Bras. Enferm."},{"issue":"12","key":"35749_CR5","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/ijc.32055","volume":"144","author":"M Araghi","year":"2019","unstructured":"Araghi, M. et al. Global trends in colorectal cancer mortality: Projections to the year 2035. Int. J. Cancer 144(12), 2992\u20133000 (2019).","journal-title":"Int. J. Cancer"},{"key":"35749_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/B978-0-12-824299-5.00008-3","volume-title":"Overcoming Drug Resistance in Gynecologic Cancers","author":"N Sabnis","year":"2021","unstructured":"Sabnis, N. et al. Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers. In Overcoming Drug Resistance in Gynecologic Cancers 77\u2013126 (Elsevier, 2021)."},{"issue":"3","key":"35749_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Global Burden of Disease Cancer C et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 8(3), 420\u201344 (2022).","journal-title":"JAMA Oncol."},{"key":"35749_CR8","unstructured":"Statistics Poland. Statistical bulletin no 6\/2019. https:\/\/stat.gov.pl\/en\/topics\/other-studies\/informations-on-socio-economic-situation\/statistical-bulletin-no-62019,4,102.html?pdf=1. Accessed 08 February 2022."},{"issue":"6","key":"35749_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0021-9681(58)90126-7","volume":"8","author":"SJ Cutler","year":"1958","unstructured":"Cutler, S. J. & Ederer, F. Maximum utilization of the life table method in analyzing survival. J. Chronic Dis. 8(6), 699\u2013712 (1958).","journal-title":"J. Chronic Dis."},{"issue":"3","key":"35749_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cmpb.2006.01.004","volume":"81","author":"M Pohar","year":"2006","unstructured":"Pohar, M. & Stare, J. Relative survival analysis in R. Comput. Methods Programs Biomed. 81(3), 272\u2013278 (2006).","journal-title":"Comput. Methods Programs Biomed."},{"issue":"9","key":"35749_CR11","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#","volume":"78","author":"H Brenner","year":"1996","unstructured":"Brenner, H. & Gefeller, O. An alternative approach to monitoring cancer patient survival. Cancer 78(9), 2004\u20132010 (1996).","journal-title":"Cancer"},{"key":"35749_CR12","unstructured":"Statistics Poland. Life expectancy in Poland - Life tables 1990 - 2019. https:\/\/stat.gov.pl\/en\/topics\/population\/life-expectancy\/. Accessed 20 March 2022."},{"issue":"7624","key":"35749_CR13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 335(7624), 806\u2013808 (2007).","journal-title":"BMJ"},{"issue":"9972","key":"35749_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani, C. et al. Global surveillance of cancer survival 1995\u20132009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972), 977\u20131010 (2015).","journal-title":"Lancet"},{"key":"35749_CR15","unstructured":"Finnish Cancer Registry. Cancer satistics, prognoses of cancer patients (survival). https:\/\/tilastot.syoparekisteri.fi\/syovat. Accessed 20 March 2022."},{"key":"35749_CR16","unstructured":"Pitk\u00e4niemi J, Malila NK, Tanskanen T, Degerlund H, Heikkinen S, Sepp\u00e4 K. Cancer in Finland 2019. Cancer Society of Finland 2021; No. 98."},{"key":"35749_CR17","volume-title":"Cancer in Norway 2019\u2014Cancer Incidence, Mortality, Survival and Prevalence in Norway","author":"Cancer Registry of Norway","year":"2020","unstructured":"Cancer Registry of Norway. Cancer in Norway 2019\u2014Cancer Incidence, Mortality, Survival and Prevalence in Norway (Cancer Registry of Norway, 2020)."},{"key":"35749_CR18","volume-title":"Cancer Incidence in the Czech Republic 2018","author":"D Krej\u010d\u00ed","year":"2019","unstructured":"Krej\u010d\u00ed, D. et al. Cancer Incidence in the Czech Republic 2018 (Institute of Health Information and Statistics of the Czech Republic, 2019)."},{"key":"35749_CR19","volume-title":"Cancer in Estonia 2017","author":"M M\u00e4gi","year":"2020","unstructured":"M\u00e4gi, M., H\u00e4rmaorg, P. & Innos, K. Cancer in Estonia 2017 (National Institute for Health Development, 2020)."},{"key":"35749_CR20","unstructured":"German Centre for Cancer Registry Data. Database query with estimates for cancer incidence. Prevalence and survival in Germany. based on data of the population based cancer registries. 2021. www.krebsdaten.de\/database. Accessed 20 March 2022."},{"key":"35749_CR21","doi-asserted-by":"publisher","first-page":"102147","DOI":"10.1016\/j.canep.2022.102147","volume":"78","author":"FL Caetano Dos Santos","year":"2022","unstructured":"Caetano Dos Santos, F. L., Wojciechowska, U., Michalek, I. & Didkowska, J. Progress in cancer survival across last two decades\u2014A nationwide study of over 1.2 million Polish patients diagnosed with the most common cancers. Cancer Epidemiol. 78, 102147 (2022).","journal-title":"Cancer Epidemiol."},{"key":"35749_CR22","volume-title":"Guidance on HPV Vaccination in EU Countries: Focus on Boys, People Living with HIV and 9-Valent HPV Vaccine Introduction","author":"European Centre for Disease Prevention and Control","year":"2020","unstructured":"European Centre for Disease Prevention and Control. Guidance on HPV Vaccination in EU Countries: Focus on Boys, People Living with HIV and 9-Valent HPV Vaccine Introduction (Stockholm, 2020)."},{"key":"35749_CR23","unstructured":"Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Geneve: World Health Organization; 2020."},{"key":"35749_CR24","unstructured":"Eurostat (2023). Health care expenditure by financing scheme. https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/HLTH_SHA11_HF__custom_5220788\/default\/table?lang=en. Accessed 6 March 2023."},{"issue":"12","key":"35749_CR25","first-page":"577","volume":"87","author":"S Schraub","year":"1992","unstructured":"Schraub, S., Alauzet, E., Schaffer, P., Robillard, J. & Menegoz, F. Descriptive epidemiology of gynecologic and breast cancers. Rev. Fr. Gynecol. Obstet. 87(12), 577\u2013585 (1992).","journal-title":"Rev. Fr. Gynecol. Obstet."},{"issue":"1","key":"35749_CR26","first-page":"1","volume":"35","author":"I Kato","year":"1989","unstructured":"Kato, I., Tominaga, S. & Kuroishi, T. The epidemiology of cancers of the female genital organs. Gan No Rinsho 35(1), 1\u20138 (1989).","journal-title":"Gan No Rinsho"},{"issue":"11","key":"35749_CR27","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold, M. et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 20(11), 1493\u20131505 (2019).","journal-title":"Lancet Oncol."},{"issue":"15","key":"35749_CR28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.ejca.2015.07.022","volume":"51","author":"M Sant","year":"2015","unstructured":"Sant, M. et al. Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: Results of the EUROCARE-5 study. Eur. J. Cancer 51(15), 2191\u20132205 (2015).","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"35749_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3109\/02841861003691945","volume":"49","author":"A Klint","year":"2010","unstructured":"Klint, A. et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964\u20132003 followed up to the end of 2006. Acta Oncol. 49(5), 632\u2013643 (2010).","journal-title":"Acta Oncol."},{"issue":"1","key":"35749_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid, B. M., Permuth, J. B. & Sellers, T. A. Epidemiology of ovarian cancer: A review. Cancer Biol. Med. 14(1), 9\u201332 (2017).","journal-title":"Cancer Biol. Med."},{"issue":"11","key":"35749_CR31","first-page":"937","volume":"93","author":"CA Doubeni","year":"2016","unstructured":"Doubeni, C. A., Doubeni, A. R. & Myers, A. E. Diagnosis and management of ovarian cancer. Am. Fam. Physician 93(11), 937\u2013944 (2016).","journal-title":"Am. Fam. Physician"},{"issue":"2","key":"35749_CR32","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health 8(2), e191\u2013e203 (2020).","journal-title":"Lancet Glob. Health"},{"key":"35749_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.08.021","volume":"194","author":"M Hartai","year":"2015","unstructured":"Hartai, M., Nyari, T. A. & McNally, R. J. Trends in mortality rates in female genital organs and breast cancers in Hungary between 1979 and 2013. Eur. J. Obstet. Gynecol. Reprod. Biol. 194, 168\u2013172 (2015).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"35749_CR34","first-page":"10","volume":"7","author":"NN Naing","year":"2000","unstructured":"Naing, N. N. Easy way to learn standardization: Direct and indirect methods. Malays. J. Med. Sci. 7(1), 10\u201315 (2000).","journal-title":"Malays. J. Med. Sci."},{"issue":"2","key":"35749_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1047-2797(98)00061-1","volume":"9","author":"PD Sorlie","year":"1999","unstructured":"Sorlie, P. D. et al. Age-adjusted death rates: Consequences of the Year 2000 standard. Ann. Epidemiol. 9(2), 93\u2013100 (1999).","journal-title":"Ann. Epidemiol."},{"key":"35749_CR36","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci Publ 1987; (82): 1\u2013406."},{"key":"35749_CR37","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980; (32): 5\u2013338."},{"key":"35749_CR38","volume-title":"Cancer Survival in Belgium","author":"Belgian Cancer Registry","year":"2012","unstructured":"Belgian Cancer Registry. Cancer Survival in Belgium (Belgian Cancer Registry, 2012)."},{"issue":"1","key":"35749_CR39","first-page":"25","volume":"60","author":"I Miljanovic-Spika","year":"2021","unstructured":"Miljanovic-Spika, I., Madunic, M. D., Topolovec, Z., Kujadin Kenjeres, D. & Vidosavljevic, D. Prognostic factors for vulvar cancer. Acta Clin. Croat. 60(1), 25\u201332 (2021).","journal-title":"Acta Clin. Croat."},{"issue":"1","key":"35749_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5603\/NJO.2021.0007","volume":"71","author":"P Koczkodaj","year":"2021","unstructured":"Koczkodaj, P., Sulkowska, U., Kami\u0144ski, M. F. & Didkowska, J. SARS-CoV-2 as a new possible long-lasting determining factor impacting cancer death numbers. Based on the example of breast, colorectal and cervical cancer in Poland. Nowotwory J. Oncol. 71(1), 42\u20136 (2021).","journal-title":"Nowotwory J. Oncol."},{"key":"35749_CR41","unstructured":"Fedorenko Z, Michailovich Y, Goulak L, et al. Cancer in Ukraine 2019 - 2020: Incidence, mortality, prevalence and other relevant statistics. Bulletin of the National Cancer Registry of Ukraine 2021; 22."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35749-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:07:22Z","timestamp":1685009242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35749-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35749"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35749-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"30 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8473"}}